Global RAC Beta Serine/Threonine Protein Kinase Market Research Report 2021

(Bussiness Sales)

(Us - Toll Free)

(Rest Of World)

Home / Categories / Healthcare

Global RAC Beta Serine/Threonine Protein Kinase Market Research Report 2021

Global RAC Beta Serine/Threonine Protein...

Report Code

RO1/130/9967

Publish Date

23/Mar/2021

PRICE

Single User Licence

$ 1800/-

This is a single user license, allowing one specific user access to the product. The product is a PDF.

Multi User Licence

$ 2350/-

This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.

Corporate User Licence

$ 2850/-

This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Report Type

PDF

REQUEST SAMPLE
ASK FOR DISCOUNT
ANY QUESTION

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
ARQ-092
AZD-5363
BAY-1125976
COTI-2
MK-2206
MK-2206
Others

Segment by Application
Brain Cancer
Colon Cancer
Metastatic Colorectal Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Almac Discovery Ltd
ArQule Inc
AstraZeneca Plc
Bayer AG
Critical Outcome Technologies Inc
Merck & Co Inc
Novartis AG